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Endoplasmic Reticulum Calcium,
Stress, and Cell-to-Cell Adhesion
Theodora Mauro1
Darier’s disease (DD) is caused by mutations in the endoplasmic reticulum (ER)
Ca2þ ATPase ATP2A2 (protein SERCA2). Current treatment modalities are
ineffective for many patients. This report shows that impaired SERCA2 function,
both in DD keratinocytes and in normal keratinocytes treated with the SERCA2-
inhibitor thapsigargin, depletes ER Ca2þ stores, leading to constitutive ER stress
and increased sensitivity to ER stressors. ER stress, in turn, leads to abnormal
cell-to-cell adhesion via impaired redistribution of desmoplakin, desmoglein 3,
desmocollin 3, and E-cadherin to the plasma membrane. This report illustrates
how ER Ca2þ depletion and the resulting ER stress are central to the pathogenesis
of the disease. Additionally, the authors introduce a possible new therapeutic
agent, miglustat.
Journal of Investigative Dermatology (2014) 134, 1800–1801. doi:10.1038/jid.2014.97
Darier’s disease
Darier’s disease (DD), caused by muta-
tions in the ER Ca2þ ATPase ATP2A2
(Sakuntabhai et al., 1999), is an un-
common (1:30,000) blistering skin
disease. Patients with DD suffer from
impaired cell-to-cell adhesion, defective
keratinocyte differentiation, and non-
physiological keratinocyte apoptosis.
Histologically, DD manifests with sup-
rabasal clefting in the epidermis,
acantholysis, rounded dyskeratotic kera-
tinocytes (‘‘corps ronds’’), hyperke-
ratosis and parakeratotic keratinocytes
in the stratum corneum (‘‘grains’’).
Current treatments, such as retinoids,
do not ameliorate the underlying defect
in ER Ca2þ sequestration, and are
ineffective for many patients.
This report, by Savignac et al. (2014,
this issue), advances our understanding
of DD in several important ways. First,
it illustrates how ER stress impairs the
formation of both adherens junctions
and desmosomes, contributing to DD
pathogenesis. Second, it expands our
understanding of how ER Ca2þ signal-
ing may control not only keratinocyte
growth and differentiation but also kera-
tinocyte cell-to-cell adhesion. Lastly, it
introduces a possible new therapeutic
agent, miglustat.
Defects in cell-to-cell adhesion in Darier’s
disease
Defects in desmoplakin redistribution
have been associated with the impaired
cell-to-cell adhesion seen in DD
(Dhitavat et al., 2003; Hobbs et al.,
2011). Defective desmoplakin redistri-
bution after SERCA2 Ca2þ depletion is
mediated by protein kinase C alpha
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(PKCalpha) (Hobbs et al., 2011).
PKCalpha also may act on desmop-
lakin to direct the ‘‘hyperadhesive’’
desmosomal state (Hobbs and Green,
2012), rearrange desmosome compo-
nents during wound healing (Garrod,
2013), and modulate desmosomal
susceptibility to autoimmune attack in
pemphigus vulgaris (Cirillo et al., 2010).
More recently, cell-to-cell adhesion
defects in DD also have been associa-
ted with defects in E-cadherin
redistribution (Celli et al., 2011). The
current report demonstrates that both
structural components are disturbed in
DD. Because both desmoplakin and
E-cadherin have been shown to have
signaling as well as structural roles
(Tu et al., 2012; Kowalczyk and
Green, 2013), it is likely that
interactions among adhesion compo-
nents involve multiple feedback loops
between each other and the SERCA2-
controlled ER Ca2þ store.
ER stress: a double-edged sword
This report also highlights the impor-
tance of ER stress. Mild and self-limited
ER stress, due to transient release and
refill of ER Ca2þ stores, is an important
physiological signal for epidermal per-
meability barrier repair and antimicro-
bial peptide synthesis (Celli et al., 2011;
Park et al., 2011). However, once ER
Ca2þ depletion passes a critical
threshold, the ER unfolded protein
response (UPR) is triggered, and
apoptotic mechanisms are initiated in
many cell types (Oakes, et al., 2003).
This report identifies ER stress, induced
by ER Ca2þ depletion due to SERCA2
dysfunction, as an important contributor
to DD pathogenesis.
Miglustat in Darier’s disease
Finally, this report demonstrates that
treatment of DD keratinocytes with
miglustat improves desmoplakin and
E-cadherin redistribution and improves
(although it does not normalize) cell-to-
cell adhesion. The authors propose
that Miglustat acts as a chaperone that
allows adhesion molecules to escape
from the ER stress-induced UPR, thus
enabling them to reach the plasma
membrane and form adherens junctions
and desmosomes. Miglustat, used clini-
cally for Gaucher disease, also acts to
inhibit glucosylceramide synthase (revi-
ewed in Venier and Igdoura (2012)), and
an additional potential therapeutic path-
way may be through its modulation of
the ceramide/sphingolipid pathway
previous described in DD pathogenesis
(Celli et al., 2012). Lastly, as glucosyl-
ceramide synthesis is required for
epidermal permeability maintenance
(Jennemann et al., 2007), some caution
should be used in extrapolating these
results from monolayer keratinocytes to
a multilayered epidermis or to patients.
As the authors note, however, thera-
peutic options for DD are limited, and
miglustat may be the first in a series of
agents that treat DD by facilitating
redistribution of adhesion molecules to
the plasma membrane.
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Clinical Implications
 Patients with Darier’s disease (DD), caused by a mutation in the endo-
plasmic reticulum (ER) ATPase SERCA2, suffer from impaired cell-to-cell
adhesion, defective keratinocyte differentiation, and non-physiological
keratinocyte apoptosis.
 Impaired SERCA2 function depletes ER Ca2þ stores, leading to constitutive
ER stress. ER stress, in turn, leads to abnormal cell-to-cell adhesion via
impaired redistribution of desmoplakin, desmoglein 3, desmocollin 3, and
E-cadherin to the plasma membrane.
 Miglustat, an agent already used as a pharmacological chaperone and
ceramide modulator, improves cell junction formation and enhances
keratinocyte adhesion strength in DD keratinocytes.
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